Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 14.70
-0.40 (-2.65%)
At close: Mar 27, 2026
Legend Biotech Revenue
In the year 2025, Legend Biotech had annual revenue of $1.03B USD with 64.02% growth. Legend Biotech had revenue of $306.38M in the quarter ending December 31, 2025, with 64.21% growth.
Revenue
$1.03B
Revenue Growth
+64.02%
P/S Ratio
3.08
Revenue / Employee
$354.79K
Employees
2,900
Market Cap
2.70B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.03B | 401.60M | 64.02% |
| Dec 31, 2024 | 627.30M | 342.20M | 120.03% |
| Dec 31, 2023 | 285.10M | 168.10M | 143.66% |
| Dec 31, 2022 | 117.01M | 48.18M | 70.00% |
| Dec 31, 2021 | 68.83M | -6.17M | -8.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest Aktiengesellschaft | 635.20M |
| 2invest AG | 28.07M |
| Darwin AG | 27.35M |
| Paion AG | 14.81M |
| co.don AG | 6.24M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |